A 6-year-old child with β-thalassemia major is admitted for routine blood transfusion. The child has been receiving regular transfusions every 3-4 weeks since age 2. Which nursing intervention is most important to implement before administering the blood transfusion?
A 6-year-old child with β-thalassemia major requires regular blood transfusions to manage severe anemia and prevent complications.
1Administer prescribed iron supplements to enhance red blood cell production
2Assess for signs of iron overload including cardiac function and liver enlargement✓ 정답
3Encourage increased dietary intake of iron-rich foods before transfusion
4Obtain baseline hemoglobin level to determine transfusion volume needed
해설
Children with β-thalassemia major who receive chronic blood transfusions are at high risk for iron overload (hemosiderosis) because each unit of blood contains significant amounts of iron that accumulates in organs over time
Core Nursing ExplanationKey Concept Analysis: This question assesses the critical nursing priority for a patient with β-thalassemia major on a chronic transfusion regimen. The core pathophysiology is that while regular transfusions correct the anemia caused by ineffective erythropoiesis, they introduce a massive exogenous iron load. The body has no active mechanism to excrete excess iron, leading to iron overload (transfusional hemosiderosis). This iron deposits in vital organs (heart, liver, endocrine glands), causing toxicity, which is the leading cause of morbidity and mortality in these patients. Therefore, monitoring for and managing iron overload is a central, lifelong aspect of their care.
Answer Rationale: Key Point! Before administering another unit of blood to a patient on chronic transfusion therapy, the most important nursing action is to assess for complications from previous transfusions, specifically iron overload. Option ② directly addresses this by focusing on assessment for signs of cardiac (e.g., arrhythmias, cardiomyopathy) and hepatic (hepatomegaly, elevated liver enzymes) involvement. This assessment informs the ongoing need for and safety of continued transfusion and the adequacy of iron chelation therapy.
Distractor Analysis:
Watch out for confusion! Option ①, "Administer prescribed iron supplements," is contraindicated and dangerous. The primary problem in thalassemia major is not dietary iron deficiency but ineffective red cell production and subsequent iron overload from transfusions. Giving additional iron would worsen toxicity.
Option ③, "Encourage increased dietary iron," is similarly incorrect for the same reason. While a balanced diet is important, actively encouraging iron-rich foods is not appropriate and could be harmful.
Option ④, "Obtain baseline hemoglobin," is a standard component of transfusion preparation to guide therapy. However, for a patient on a routine, scheduled transfusion regimen, the hemoglobin level is expected to be low. The more critical and specific pre-transfusion action is assessing for the life-threatening complication of their chronic therapy—iron overload. The hemoglobin check is important but not the "most important" unique intervention for this specific patient's long-term risk.
Related Concepts: The management of β-thalassemia major is a balance between treating anemia (transfusions) and preventing iron overload (chelation therapy with drugs like deferoxamine, deferasirox, or deferiprone). Nursing care focuses on monitoring for complications of both the disease (bone deformities, growth retardation) and its treatment (transfusion reactions, chelator side effects).
Concept Summary
Concept
Description
Nursing Implication
β-thalassemia Major
Genetic disorder causing severe deficiency in β-globin chain production, leading to ineffective erythropoiesis and severe anemia.
Lifelong management with transfusions and iron chelation. Monitor growth, development, and organ function.
Transfusional Iron Overload (Hemosiderosis)
Accumulation of iron in body tissues (heart, liver, endocrine glands) due to chronic red blood cell transfusions.
Primary cause of death (cardiac failure). Requires vigilant assessment and adherence to chelation therapy.
Iron Chelation Therapy
Pharmacologic treatment to bind and remove excess iron from the body (e.g., deferoxamine IV/SC, deferasirox oral).
Ensure adherence, manage side effects (visual/auditory changes, GI upset, renal toxicity), and monitor serum ferritin levels.
Chronic Transfusion Therapy
Regular packed red blood cell (PRBC) transfusions to maintain hemoglobin >9-10 g/dL, suppressing ineffective erythropoiesis.
Prevent and monitor for transfusion reactions. Schedule to minimize alloimmunization risk. Avoid iron supplements.
Side-by-Side Comparison!
Assessment Focus
Iron Deficiency Anemia
Thalassemia Major with Iron Overload
Primary Problem
Insufficient iron for hemoglobin synthesis.
Ineffective erythropoiesis + Excess iron from transfusions.
Dietary/Nutritional Intervention
Encourage iron-rich foods and supplements.
Avoid/Restrict iron-rich foods and never give iron supplements.
Key Laboratory Values
Low serum iron, Low ferritin, High TIBC (Total Iron-Binding Capacity).
High serum iron, High serum ferritin (marker of iron stores), Low TIBC.
Priority Nursing Assessment
Signs of anemia (fatigue, pallor), dietary history, potential blood loss.
Signs of iron overload toxicity (cardiac, hepatic, endocrine dysfunction).
Anatomy, Physiology & Pharmacology PointsPathophysiology: In β-thalassemia, reduced β-globin leads to excess unpaired α-globin chains that precipitate in red cell precursors, causing their destruction in the bone marrow (ineffective erythropoiesis). This results in severe anemia, compensatory bone marrow expansion, and extramedullary hematopoiesis.
Iron Metabolism: Each unit of packed red blood cells contains ~200-250 mg of iron. The body can only excrete about 1 mg/day. Chronic transfusions far exceed this, leading to accumulation.
Pharmacology - Chelators: Deferoxamine binds free iron; Deferasirox and deferiprone bind intracellular iron. They form complexes excreted in urine/feces. Monitoring for ototoxicity, ocular toxicity, and renal/hepatic function is crucial.
Memory TipsAcronym: T.I.C. for Thalassemia Iron Complications: Think of the "TIC" of a clock reminding you to check regularly.
T - Toxicity (Cardiac, Liver)
I - Iron Overload is the issue
C - Chelation is key, not supplementation
Mnemonic: "NO IRON HERE" for Thalassemia Major: No supplements, Overload risk; Inspect Heart, Respiratory, Organs (liver), Needs chelation; Hemosiderosis, Evaluate ferritin, Regular transfusions, Education vital.
High-Frequency NCLEX Topics
This integrates several high-yield NCLEX areas: Pediatric chronic illness management, complications of medical treatments (transfusion therapy), priority setting (assessing for life-threatening complications vs. routine tasks), and patient education for lifelong therapy. NCLEX often tests the contraindication of iron supplements in thalassemia and the nurse's role in monitoring for iron overload.
Watch Out for Question Variations!
* Shift from Assessment to Intervention: "The nurse identifies signs of iron overload in a child with thalassemia. Which intervention should the nurse anticipate?" (Answer: Administration of iron chelating agents).
* Patient Education Focus: "Which statement by the parent of a child with thalassemia indicates understanding of the treatment plan?" (Correct: "I will give the deferasirox medication every day as prescribed." Incorrect: "I will add more red meat and spinach to his diet.").
* Lab Value Interpretation: Present a serum ferritin level of 3500 ng/mL (Normal: ~20-300 ng/mL) and ask for the priority nursing action.
Nursing Clinical Practice GuideClinical Scenario: You are the nurse in a pediatric hematology clinic. Jason, a 6-year-old with β-thalassemia major, arrives for his scheduled monthly blood transfusion. His mother reports he has been more tired than usual after school and sometimes complains of "his heart beating fast." His last serum ferritin level 3 months ago was 2800 ng/mL.
Nursing Intervention Strategy:
1AssessmentBefore starting the transfusion, perform a focused assessment for iron overload.
* Cardiac: Auscultate heart sounds for gallops or murmurs; assess heart rate and rhythm; ask about palpitations, exercise intolerance, or shortness of breath.
* Hepatic: Palpate for hepatomegaly (right upper quadrant mass); note any scleral icterus or abdominal distension.
* Other Systems: Inquire about symptoms of endocrine dysfunction (delayed growth/puberty, polyuria/polydipsia suggestive of diabetes).
* Medication Adherence: Gently inquire about consistency with oral chelation therapy (deferasirox).
2Planning & Implementation* Document findings and report significant changes (new murmur, hepatomegaly) to the provider. This may prompt more frequent cardiac MRI (T2*) or liver iron concentration checks.
* Proceed with standard blood transfusion protocol: verify order, obtain informed consent, check blood products against two patient identifiers, use appropriate filter and tubing, start infusion slowly for first 15 minutes, monitor vital signs per protocol.
* Provide education reinforcement: Praise adherence to chelation. Explain that tiredness and palpitations could be signs of anemia OR iron affecting the heart, highlighting why chelation is so important.
3EvaluationMonitor for both acute transfusion reactions and long-term trends in organ function through lab work and imaging.
Patient Safety and Precautions:
* Absolute Contraindication: Never administer iron supplements or encourage high-iron diets.
* Transfusion Safety: Use leukocyte-reduced blood products to minimize febrile reactions and alloimmunization risk.
* Chelation Therapy: Monitor for side effects specific to the agent (e.g., auditory/visual testing for deferoxamine, renal/hepatic function for deferasirox).
Nursing Procedure & Medication FlowPre-Transfusion for Chronic Thalassemia Patient:
1. Review chart for latest ferritin level and organ function tests (ECHO, liver MRI, endocrine labs).
2. Perform focused physical assessment for iron overload toxicity (cardiac, hepatic).
3. Verify the type and crossmatch and that the blood product is leukoreduced.
4. Obtain vital signs and baseline hemoglobin.
5. Educate family on the dual goals: transfusion for anemia, chelation for iron.Medication: Iron Chelators
* Deferoxamine: Typically subcutaneous infusion via pump over 8-12 hours, 5-7 nights/week. Site rotation is crucial to prevent skin reactions.
* Deferasirox: Oral, once daily. Must be taken on an empty stomach 30 minutes before food, dispersed in water/orange juice/apple juice. Do not take with aluminum-containing antacids.
A Word from Your Senior Nurse
"Caring for children with chronic conditions like thalassemia teaches you that nursing is about managing the disease AND its treatment. That next blood transfusion is life-saving, but it's also adding to a toxic iron load. Your sharp assessment skills for subtle signs of cardiac strain or liver enlargement are what bridge the gap between routine care and preventing a life-threatening complication. On the NCLEX and at the bedside, always think beyond the immediate task. Ask yourself: 'What is the biggest threat to this patient's well-being right now?' For Jason, it's not the low hemoglobin—it's the iron silently accumulating in his heart. That's the thinking that makes an exceptional nurse."
β-thalassemia Major — A severe genetic blood disorder characterized by deficient synthesis of β-globin chains, leading to ineffective erythropoiesis, severe anemia, and requiring lifelong blood transfusions.
Transfusional Iron Overload — The pathological accumulation of iron in body tissues (especially heart, liver, endocrine glands) as a complication of chronic red blood cell transfusions, leading to organ dysfunction.
Iron Chelation Therapy — Pharmacologic treatment using agents (e.g., deferoxamine, deferasirox) to bind excess iron and promote its excretion from the body, preventing toxicity from iron overload.
Ineffective Erythropoiesis — The impaired production of mature, functional red blood cells in the bone marrow, a hallmark of thalassemia and other bone marrow disorders, leading to anemia despite cellular marrow.
Alloimmunization — The development of antibodies against foreign antigens (e.g., on transfused red blood cells), a risk of chronic transfusion therapy that can complicate future transfusions.